Pavel Klein

Mid Atlantic Epilepsy and Sleep Center — United States

Medicine · Health Sciences

35h-index4.5kcitations186works9.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epilepsy research and treatment(135), Pharmacological Effects and Toxicity Studies(96), Neuroscience and Neuropharmacology Research(62), Education, Psychology, and Social Research(14), European Cultural and National Identity(13)

Publications186 total

Inflammatory proteins as acute biomarkers of post-traumatic epilepsy
Frontiers in Neurology·2025Open Access
Pharmacokinetics and tolerability of single‐dose Staccato® alprazolam in adolescents with epilepsy, and population pharmacokinetic analysis to support dose selection in adolescents
Epilepsia·2025Open Access
Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy
Neurology·2025· 1 citedOpen Access
Efficacy, safety and tolerability of adjunctive cenobamate in pediatric and adult patients with Lennox Gastaut Syndrome
Epilepsy & Behavior·2025· 6 cited
Academia, industry and the slow adoption of new treatments
Brain·2025Open Access
Exploring proposed recommendations for immediate‐use seizure medication: Treating both cluster and prolonged seizures with diazepam nasal spray
Epilepsia Open·2025Open Access
Pharmacodynamic interactions between seletracetam and antiseizure comedications in the human photosensitivity model
Epilepsia·2025Open Access
Exploring Proposed Recommendations for Acute Cluster Treatment and Rapid and Early Seizure Termination Using Data From a Long-Term Safety Study of Diazepam Nasal Spray (P12-9.004)
Neurology·2025
Clinical trials of prevention of acquired epilepsy: New proof‐of‐concept approach to restart trials
Epilepsia·2025· 2 cited
Seizure freedom and reducing the risk of sudden unexpected death in patients with focal epilepsy treated with cenobamate or other antiseizure medications
Epilepsia·2025· 2 citedOpen Access
Cenobamate efficacy in specific populations
Epilepsia·2025· 3 citedOpen Access
Focal to bilateral tonic–clonic seizures in newly diagnosed focal epilepsy
Epilepsia·2025Open Access
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma
BMC Medicine·2024· 32 citedOpen Access
Recent Advances in Pharmacologic Treatments of Drug-Resistant Epilepsy: Breakthrough in Sight
CNS Drugs·2024· 17 cited
A comparison of the antiepileptogenic efficacy of two rationally chosen multitargeted drug combinations in a rat model of posttraumatic epilepsy
Experimental Neurology·2024· 2 citedOpen Access
The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy
Neurology·2024· 13 cited
New epilepsy therapies in development
Nature Reviews Drug Discovery·2024· 101 cited
Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher‐level emergency: Consensus recommendations of an expert working group
Epileptic Disorders·2024· 26 citedOpen Access
Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy
Advances in Therapy·2024· 15 citedOpen Access
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study
Journal of Neurology·2024· 7 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Michael R. Sperling(14), Gregory L. Krauss(11), Wolfgang Löscher(6), Christian Brandt(6), Bernhard J. Steinhoff(6), John Whitesides(6), Sami Aboumatar(6), William E. Rosenfeld(6), Bassel Abou‐Khalil(6), Orrin Devinsky(5), Jimmy Schiemann(5), David G. Vossler(5), Robert Wechsler(5), Ivana Tyrlíková(5), Phillip L. Pearl(4), Robert McCarter(4), Victor Biton(4), Jacqueline A. French(4), Lawrence J. Hirsch(3), Henrik Klitgaard(3)